Innoviva (INVA) Operating Margin Growth (3y) (2014 - 2026)
Innoviva (INVA) Operating Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Operating Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Innoviva |
1.65 Bn |
1.05 Bn |
75.83 Mn |
146,431.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
146,431.00 |
| Dec 31, 2025 |
-29,133.00 |
| Sep 30, 2025 |
3,169.00 |
| Jun 30, 2025 |
53,826.00 |
| Mar 31, 2025 |
75,669.00 |
| Dec 31, 2024 |
-24,183.00 |
| Sep 30, 2024 |
-4,831.00 |
| Jun 30, 2024 |
-821,067.00 |
| Mar 31, 2024 |
-54,895.00 |
| Dec 31, 2023 |
84,986.00 |
| Sep 30, 2023 |
3,260.00 |
| Jun 30, 2023 |
-107,855.00 |
| Mar 31, 2023 |
-152,212.00 |
| Dec 31, 2022 |
-107,961.00 |
| Sep 30, 2022 |
-9,207.00 |
| Jun 30, 2022 |
-58,286.00 |
| Mar 31, 2022 |
-80,449.00 |
| Dec 31, 2021 |
-70,822.00 |
| Sep 30, 2021 |
313.00 |
| Jun 30, 2021 |
817,199.00 |
